Precision medicine to personalize medicine in allergic airway disease.

Abstract

The purpose of this study is to understand the approach to precision medicine and personalized medicine in the management of allergic airway disease. Identification of biomarkers as key tools used in precision medicine has led to the development of multiple biologic drugs being used as new treatments for allergic airway disease. In addition to these advances, there is still much needed effort to improve the feasibility and utility of integrating biologic omics data of precision medicine with physicochemical, behavioral, psychological, and social data to deliver optimized treatments that is personalized for each individual.